Trump’s Iran war looks reckless. But if Tehran’s military and proxy powers are being systematically weakened, his critics may be missing something

The Israel-Iran conflict marks the emergence of a new chapter in nuclear rivalries that may reshape proliferation risks for years to come

Renergen surprised the market with news of a proposed merger with Nasdaq-listed ASP Isotopes. It’s had a galvanising effect on the company’s shares

South Africa’s nuclear ambitions are back with a bang. But the odds of new nuclear assets going online any time soon are slim